These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16105873)

  • 1. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
    Coban S; Ceydilek B; Ekiz F; Erden E; Soykan I
    Ann Pharmacother; 2005 Oct; 39(10):1737-40. PubMed ID: 16105873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
    Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
    Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fulminant hepatitis caused by disulfiram].
    Zala G; Schmid M; Bühler H
    Dtsch Med Wochenschr; 1993 Sep; 118(38):1355-60. PubMed ID: 8404476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute rhabdomyolysis associated with ofloxacin/levofloxacin therapy.
    Hsiao SH; Chang CM; Tsao CJ; Lee YY; Hsu MY; Wu TJ
    Ann Pharmacother; 2005 Jan; 39(1):146-9. PubMed ID: 15562138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure.
    Christie MJ; Wong K; Ting RH; Tam PY; Sikaneta TG
    Ann Pharmacother; 2005 May; 39(5):953-5. PubMed ID: 15827068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A fatal case of a hepatitis B virus carrier with fulminant hepatic failure after cytotoxic chemotherapy for malignant lymphoma].
    Kumagai K; Takagi T; Sakai C; Oguro M; Kawai S; Nakahori S; Yokosuka O; Ohtoh M
    Rinsho Ketsueki; 1993 Dec; 34(12):1587-9. PubMed ID: 8295335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis.
    Viruet EJ; Torres EA
    P R Health Sci J; 1998 Sep; 17(3):297-300. PubMed ID: 9883478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative).
    Tameda Y; Hamada M; Takase K; Nakano T; Kosaka Y
    Hepatology; 1996 Mar; 23(3):465-70. PubMed ID: 8617425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis GBV isolated in acute liver failure. Successful outcome after liver transplantation].
    Broomé U; Ericzon BG; Eleborg L; Stål P; Oksanen A; Sönnerborg A
    Lakartidningen; 1997 Oct; 94(40):3519-20, 3523. PubMed ID: 9411092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
    Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
    J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis associated with the use of levofloxacin.
    Figueira-Coelho J; Pereira O; Picado B; Mendonça P; Neves-Costa J; Neta J
    Clin Ther; 2010 Sep; 32(10):1733-7. PubMed ID: 21194596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple organ failure syndrome in fulminant hepatic failure].
    Andresen M; Arrese M; Dussaillant G; Dougnac A; Campusano C; Glasinovic JC
    Rev Med Chil; 1994 Jun; 122(6):661-6. PubMed ID: 7732210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: fulminant hepatic failure involving duloxetine hydrochloride.
    Hanje AJ; Pell LJ; Votolato NA; Frankel WL; Kirkpatrick RB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):912-7. PubMed ID: 16797245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
    Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
    Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections.
    Khashab MM; Xiang J; Kahn JB
    Curr Med Res Opin; 2006 Oct; 22(10):1997-2006. PubMed ID: 17022859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probable sulbactam/ampicillin-associated prolonged cholestasis.
    Köklü S; Köksal AS; Asil M; Kiyici H; Coban S; Arhan M
    Ann Pharmacother; 2004 Dec; 38(12):2055-8. PubMed ID: 15494387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine.
    Nykamp DL; Blackmon CL; Schmidt PE; Roberson AG
    Ann Pharmacother; 2005 Mar; 39(3):543-6. PubMed ID: 15687478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid progression of encephalopathy in a patient with hepatitis B infection.
    Takemura N; Sugawara Y; Tamura S; Kakeno J; Matsui Y; Makuuchi M
    Biosci Trends; 2007 Aug; 1(1):7-9. PubMed ID: 20103860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.